Glaucoma Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

MARKET INTRODUCTION

The medical condition where eye's optic nerve is damaged is termed as glaucoma. The most common glaucoma condition is inherited and often may not show later in life. People with diabetes are at risk of developing this condition. If not treated on time it may lead to visual loss.

MARKET DYNAMICS

The Glaucoma market is anticipated to grow in the forecast, owing to rising geriatric population, growing prevalence of diabetes and newly developed technologies to treat glaucoma. In addition, the growing adoption of laser surgery to treat glaucoma is expected to offer significant growth opportunities in the market during the forecast period.

MARKET SCOPE

The "Global Glaucoma market Analysis to 2031" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of Glaucoma market with detailed market segmentation by disease indication, surgery, drug class, end users and geography. The global Glaucoma market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Glaucoma market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global Glaucoma market is segmented on the basis of disease indication, surgery, drug class, end users. Based on disease indication, the market is segmented as, closed angle glaucoma (CAG), open angle glaucoma (OAG), secondary glaucoma, congenital glaucoma and other. Based on drug class, the market is segmented in to prostaglandin analogs (PGAS), alpha agonist, beta blockers, cholinergic drugs, carbonic anhydrase inhibitors and others. Based on surgery the market is segmented into laser iridotomy, laser trabeculoplasty, aqueous shunt surgery and peripheral iridectomy. On the basis of end user, the glaucoma market is categorized as hospitals, clinics, home users.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Glaucoma market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Glaucoma market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Glaucoma market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Glaucoma market in these regions.

Glaucoma Market Report Analysis

Glaucoma Market

• 
  CAGR (2023 - 2031)

  XX%
• Market Size 2023
  US$ XX Million
• Market Size 2031
  US$ XX Million

Report Coverage

• Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope

• Key future trends
• Detailed PEST/Porter’s Five Forces and SWOT analysis

• Industry landscape and competition analysis & recent developments
• Detailed company profiles

• Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

• Novartis AG
• Pfizer Inc.
• Allergan
• Merck & Co
• Ocular Therapeutix Inc
• pSivida Corp
• Icon Bioscience Inc
• Amorphex Therapeutics LLC.
• Ellex

Regional Overview

• North America
• Europe
• Asia-Pacific
• South and Central America
• Middle East and Africa

Market Segmentation

By Disease Indication

• Closed Angle Glaucoma
• Open Angle Glaucoma
• Secondary Glaucoma
• Congenital Glaucoma

By Drug class

• Prostaglandin Analogs
• Alpha Agonist
• Beta Blockers
• Cholinergic Drugs
• Carbonic Anhydrase Inhibitors

By Surgery

• Laser Iridotomy
• Laser Trabeculoplasty
• Aqueous Shunt Surgery and Peripheral Iridectomy

By End Users

• Hospitals
• Clinics
• Home Users

MARKET PLAYERS

The reports cover key developments in the Glaucoma market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Glaucoma market are anticipated to lucrative growth opportunities in the future with the rising demand for Glaucoma market in the global market. Below mentioned is the list of few companies engaged in the Glaucoma market.

The report also includes the profiles of key Glaucoma market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

•  Novartis AG
•  Pfizer Inc.
•  Allergan
•  Merck & Co
• cular Therapeutix Inc
•  pSivida Corp
•  Icon Bioscience Inc
•  Amorphex Therapeutics LLC.
•  Ellex
•  Quantel

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Glaucoma Market Report Scope